Impaired early insulin secretion in Japanese type 2 diabetes with metabolic syndrome

被引:12
作者
Fukuda-Akita, Etsuko [1 ]
Okita, Kohei [1 ]
Okauchi, Yukiyoshi [1 ]
Ryo, Miwa [1 ]
Nakamura, Tadashi [1 ]
Funahashi, Tohru [1 ]
Iwahashi, Hiromi [1 ]
Shimomura, Iichiro [1 ]
Miyagawa, Junichiro [2 ]
Yamagata, Kazuya [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan
[2] Hyogo Coll Med, Div Diabet & Metab, Kobe, Hyogo, Japan
关键词
metabolic syndrome; type; 2; diabetes; early insulin secretion; insulinogenic index;
D O I
10.1016/j.diabres.2007.10.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although it is widely believed that type 2 diabetics with metabolic syndrome (MS) have insulin resistance, the beta-cell function of these patients is largely unknown. We evaluated the characteristics of insulin secretion in Japanese type 2 diabetics with MS after minimizing the influence of glucotoxity. A 75-g OGTT was performed in 192 diabetic subjects and 275 subjects with normal glucose tolerance (NGT). Although there was no significant difference of the AUC (insulin(0-120)) between the MS group and the NGT group, the insulinogenic index (I.I.) was significantly lower in MS patients compared with NGT subjects. The BMI, maximum BMI, waist circumference, and VFA were all positively correlated with I.I. in the MS group (r = 0.298-0.376). By stepwise multiple regression analysis, the BMI was shown to be an independent determinant of I.I. in the MS group (standardized regression coefficient: 0.376, p = 0.0004), and it accounted for 13% of thevariance in I.I. The impaired I.I. was also found in the MS group with untreated type 2 diabetes. These results indicate that early insulin secretion is impaired in type 2 diabetics with MS. The positive association between BMI and I.I. in diabetics with MS maybe explained by beta-cell compensation for reduced insulin sensitivity. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:482 / 489
页数:8
相关论文
共 30 条
[1]   NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].
Alexander, CM ;
Landsman, PB ;
Teutsch, SM ;
Haffner, SM .
DIABETES, 2003, 52 (05) :1210-1214
[2]  
[Anonymous], 2005, Nihon Naika Gakkai Zasshi, V94, P794
[3]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[4]   PATHOGENESIS OF NIDDM - A BALANCED OVERVIEW [J].
DEFRONZO, RA ;
BONADONNA, RC ;
FERRANNINI, E .
DIABETES CARE, 1992, 15 (03) :318-368
[5]   Reduced β-cell compensation to the insulin resistance associated with obesity in members of Caucasian familial type 2 diabetic kindreds [J].
Elbein, SC ;
Wegner, K ;
Kahn, SE .
DIABETES CARE, 2000, 23 (02) :221-227
[6]  
FUKUMOTO Y, 1977, ENDOCRINOL JAPON, V24, P457
[7]   Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study [J].
Gastaldelli, A ;
Ferrannini, E ;
Miyazaki, Y ;
Matsuda, M ;
DeFronzo, RA .
DIABETOLOGIA, 2004, 47 (01) :31-39
[8]   Definition of metabolic syndrome - Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition [J].
Grundy, SM ;
Brewer, HB ;
Cleeman, JI ;
Smith, SC ;
Lenfant, C .
CIRCULATION, 2004, 109 (03) :433-438
[9]   Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia [J].
Hanefeld, M ;
Bouter, KP ;
Dickinson, S ;
Guitard, C .
DIABETES CARE, 2000, 23 (02) :202-207
[10]   Identification of subjects with insulin resistance and β-cell dysfunction using alternative definitions of the metabolic syndrome [J].
Hanley, AJG ;
Wagenknecht, LE ;
D'Agostino, RB ;
Zinman, B ;
Haffner, SM .
DIABETES, 2003, 52 (11) :2740-2747